Why the study?
HFpEF is poorly understood at the molecular level, and specific genes associated with clinical decompensation have not been identified.
Does a myocardial gene expression signature better predict event-free survival in HFpEF compared to clinical and hemodynamic parameters?
Does a myocardial gene expression signature better predict event-free survival in HFpEF compared to clinical and hemodynamic parameters?
A 33-gene myocardial expression signature identified via random survival forests outperformed traditional clinical and hemodynamic parameters in predicting event-free survival in HFpEF.
Gene signature may refine HFpEF prognostication in this cohort; hypothesis-generating and should not yet change practice.
Heart failure with preserved ejection fraction (HFpEF) continues to be poorly understood at the molecular level. While previous studies have identified gene expression signatures unique to HFpEF, genes associated with clinical decompensation have not been determined. Here, we performed exploratory analysis of myocardial RNA-seq data to identify genes associated with event-free survival in HFpEF. We analyzed previously published RNA sequencing data of right ventricular septal endomyocardial biopsies from HFpEF patients (n=41) with paired clinical, echocardiographic, and outcome data (including mortality and heart failure hospitalizations). We constructed random survival forests with forward stepwise regularization (the “variable hunting” method) to determine genes associated with time to first event using a combined end-point of heart failure hospitalization or all-cause death. Selection of candidate forest variables was tested with both random and weighted sampling methods. We identified 33 genes that are predictive of survival in HFpEF. This set includes genes previously implicated in heart failure, including ADAMTSL2, ADRB1, BMP6, and METRNL. Survival forests constructed using these genes outperform those constructed from clinical and hemodynamic parameters alone (out-of-bag C-index 0.894 vs 0.545). Moreover, in survival forests constructed from both gene data and hemodynamic measurements, individual survival genes consistently showed higher variable importance than clinical/hemodynamic parameters. Our study shows that random survival forests identify myocardial gene signatures that may better model HFpEF prognosis than clinical measurements. Further studies are warranted to validate findings in independent cohorts.
No takes yet. Share an insight, caveat, or question.
Kannan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: